114 related articles for article (PubMed ID: 12586812)
1. Skp2 protein expression in soft tissue sarcomas.
Oliveira AM; Okuno SH; Nascimento AG; Lloyd RV
J Clin Oncol; 2003 Feb; 21(4):722-7. PubMed ID: 12586812
[TBL] [Abstract][Full Text] [Related]
2. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation.
Penin RM; Fernandez-Figueras MT; Puig L; Rex J; Ferrandiz C; Ariza A
Mod Pathol; 2002 Nov; 15(11):1227-35. PubMed ID: 12429803
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
5. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
6. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
7. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
[TBL] [Abstract][Full Text] [Related]
8. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
9. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS
Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407
[TBL] [Abstract][Full Text] [Related]
10. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
12. Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.
Miyamoto T; Horiuchi A; Kashima H; Suzuki A; Yamada T; Kurai M; Konishi I; Shiozawa T
Gynecol Endocrinol; 2010 Mar; 26(3):220-9. PubMed ID: 19724954
[TBL] [Abstract][Full Text] [Related]
13. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma.
Seki R; Okamura T; Koga H; Yakushiji K; Hashiguchi M; Yoshimoto K; Ogata H; Imamura R; Nakashima Y; Kage M; Ueno T; Sata M
Am J Hematol; 2003 Aug; 73(4):230-5. PubMed ID: 12879424
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
16. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
17. Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis.
Min YH; Cheong JW; Lee MH; Kim JY; Lee ST; Hahn JS; Ko YW
Clin Cancer Res; 2004 Aug; 10(15):5123-30. PubMed ID: 15297415
[TBL] [Abstract][Full Text] [Related]
18. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
Oncol Rep; 2003; 10(2):321-5. PubMed ID: 12579266
[TBL] [Abstract][Full Text] [Related]
19. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
